chr17-40628788-T-C
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 4P and 1B. PM2PP3_ModerateBP6
The NM_003079.5(SMARCE1):c.1233A>G(p.Glu411Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,459,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003079.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- familial meningiomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, G2P, Ambry Genetics
- Coffin-Siris syndrome 5Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Coffin-Siris syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial multiple meningiomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCE1 | NM_003079.5 | c.1233A>G | p.Glu411Glu | synonymous_variant | Exon 11 of 11 | ENST00000348513.12 | NP_003070.3 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1459148Hom.: 0 Cov.: 29 AF XY: 0.00000138 AC XY: 1AN XY: 726066 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:1
The c.1233A>G variant (also known as p.E411E), located in coding exon 10 of the SMARCE1 gene, results from an A to G substitution at nucleotide position 1233. This nucleotide substitution does not change the glutamic acid (E) at codon 411. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site; however, direct evidence is insufficient at this time (Ambry internal data). Loss-of-function variants in SMARCE1 are known to cause increased risk of meningiomas; however, such associations with neurodevelopmental disorders are exceedingly rare (Kosho T et al. Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):262-75; Smith JM et al. Nat Genet. 2013 Mar;45(3):295-8). Based on the available evidence, the clinical significance of this alteration remains unclear. -
Familial meningioma Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at